TW200806288A - Bilayer tablet comprising Telmisartan and diuretic - Google Patents
Bilayer tablet comprising Telmisartan and diureticInfo
- Publication number
- TW200806288A TW200806288A TW095143437A TW95143437A TW200806288A TW 200806288 A TW200806288 A TW 200806288A TW 095143437 A TW095143437 A TW 095143437A TW 95143437 A TW95143437 A TW 95143437A TW 200806288 A TW200806288 A TW 200806288A
- Authority
- TW
- Taiwan
- Prior art keywords
- diuretic
- telmisartan
- bilayer tablet
- layer containing
- tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/02—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space
- B30B11/08—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with moulds carried by a turntable
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05025601 | 2005-11-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200806288A true TW200806288A (en) | 2008-02-01 |
Family
ID=38067569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW095143437A TW200806288A (en) | 2005-11-24 | 2006-11-23 | Bilayer tablet comprising Telmisartan and diuretic |
Country Status (7)
Country | Link |
---|---|
US (1) | US8637078B2 (zh) |
EP (1) | EP1959934A2 (zh) |
JP (2) | JP2009517366A (zh) |
AR (1) | AR057932A1 (zh) |
CA (1) | CA2625404C (zh) |
TW (1) | TW200806288A (zh) |
WO (1) | WO2007060170A2 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8115011B2 (en) | 2007-05-22 | 2012-02-14 | Madrigal Pharmaceuticals, Inc. | Diacylglycerol acyltransferase inhibitors |
EP2203158A4 (en) | 2007-10-30 | 2012-12-26 | Reddys Lab Ltd Dr | PHARMACEUTICAL FORMULATIONS WITH TELMISARTAN AND HYDROCHLORTHIAZIDE |
CA2715350C (en) | 2008-03-19 | 2017-02-14 | Ratiopharm Gmbh | Solid pharmaceutical composition comprising a non-peptide angiotensin ii receptor antagonist and a diuretic |
WO2009135646A2 (en) | 2008-05-05 | 2009-11-12 | Farmaprojects, Sa | Stable pharmaceutical compositions and their processes for preparation suitable for industrial scale |
CZ301299B6 (cs) | 2008-11-24 | 2010-01-06 | Zentiva, A.S. | Pevná farmaceutická kompozice s úcinnými látkami atorvastatinem a telmisartanem |
WO2010146187A2 (en) | 2009-06-19 | 2010-12-23 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of telmisartan |
TR200906506A2 (tr) | 2009-08-24 | 2011-03-21 | Bi̇lgi̇ç Mahmut | Telmisartan içeren katı dozaj formları. |
JP2011136908A (ja) * | 2009-12-25 | 2011-07-14 | Kyowa Yakuhin Kogyo Kk | アンギオテンシンii受容体拮抗剤を含む固形製剤および固形製剤におけるアンギオテンシンii受容体拮抗剤の保存安定性向上方法 |
WO2011161123A2 (en) | 2010-06-21 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Multilayer pharmaceutical tablet comprising telmisartan and a diuretic |
JP5818219B2 (ja) * | 2012-05-14 | 2015-11-18 | 塩野義製薬株式会社 | 6,7−不飽和−7−カルバモイルモルヒナン誘導体含有製剤 |
JP6018420B2 (ja) * | 2012-06-05 | 2016-11-02 | ニプロ株式会社 | アンジオテンシンii受容体拮抗薬およびサイアザイド系利尿薬を含む医薬組成物 |
WO2014119767A1 (ja) | 2013-01-31 | 2014-08-07 | 沢井製薬株式会社 | テルミサルタンとヒドロクロロチアジドとを含有する多層錠剤 |
JP6218664B2 (ja) * | 2013-04-04 | 2017-10-25 | 沢井製薬株式会社 | テルミサルタン含有錠剤 |
CN108524460B (zh) * | 2018-05-14 | 2021-01-01 | 佛山市南海东方澳龙制药有限公司 | 烯啶虫胺双层片 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6263520A (ja) * | 1985-09-14 | 1987-03-20 | Kyorin Pharmaceut Co Ltd | 抗リウマチ剤 |
TW235239B (zh) * | 1992-11-20 | 1994-12-01 | Pfizer | |
AU676315B2 (en) * | 1993-06-30 | 1997-03-06 | Takeda Chemical Industries Ltd. | Stabilized solid pharmaceutical preparation and method of producing the same |
JP3220373B2 (ja) * | 1995-11-28 | 2001-10-22 | バイエル薬品株式会社 | 持続性ニフエジピン製剤 |
JPH1053520A (ja) * | 1996-06-03 | 1998-02-24 | Takeda Chem Ind Ltd | 抗疲労剤 |
US5906852A (en) * | 1997-11-04 | 1999-05-25 | Nabisco, Inc. | Surface-modified cellulose as low calorie flour replacements |
WO2000027397A1 (en) * | 1998-11-06 | 2000-05-18 | Glaxo Group Limited | Antihypertensive medicaments containing lacidipine and telmisartan |
FR2787330A1 (fr) | 1998-12-18 | 2000-06-23 | Sanofi Sa | Composition pharmaceutique contenant, en association, un antagoniste des recepteurs at1 de l'angiotensine ii et un immunosuppresseur pour la prevention ou le traitement des complications vasculaires du rejet de greffe |
DE19901921C2 (de) | 1999-01-19 | 2001-01-04 | Boehringer Ingelheim Pharma | Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels |
EP1054019A1 (en) * | 1999-05-18 | 2000-11-22 | Shin-Etsu Chemical Co., Ltd. | Low-substituted hydroxypropyl cellulose |
KR20030097892A (ko) * | 2001-05-25 | 2003-12-31 | 에스에스 세야쿠 가부시키 가이샤 | 의약 배합제 |
PT1854454E (pt) | 2002-01-16 | 2014-01-09 | Boehringer Ingelheim Pharma | Método para a preparação de telmisartan amorfo |
US20040028505A1 (en) * | 2002-06-07 | 2004-02-12 | Bilbrey Robert A. | Document tape binding system with automatic tape feed, tape indicia sensing, spine printing method and post-bind automation mechanisms |
US8980870B2 (en) * | 2002-09-24 | 2015-03-17 | Boehringer Ingelheim International Gmbh | Solid telmisartan pharmaceutical formulations |
DE10244681A1 (de) * | 2002-09-24 | 2004-04-08 | Boehringer Ingelheim International Gmbh | Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung |
DE10319450A1 (de) | 2003-04-30 | 2004-11-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmazeutische Formulierung des Telmisartan Natriumsalzes |
JP2009513543A (ja) | 2003-07-16 | 2009-04-02 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | クロルタリドンの組み合わせ |
DE102004008804A1 (de) * | 2004-02-20 | 2005-09-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Mehrschichttablette |
JP2008524136A (ja) | 2004-12-17 | 2008-07-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | テルミサルタンとヒドロクロロチアジドを含む併用療法 |
JP2009515956A (ja) * | 2005-11-22 | 2009-04-16 | テバ ファーマシューティカル インダストリーズ リミティド | テルミサルタンの医薬組成物 |
-
2006
- 2006-11-15 US US11/560,059 patent/US8637078B2/en active Active
- 2006-11-22 CA CA2625404A patent/CA2625404C/en not_active Expired - Fee Related
- 2006-11-22 JP JP2008541736A patent/JP2009517366A/ja active Pending
- 2006-11-22 EP EP06819653A patent/EP1959934A2/en not_active Withdrawn
- 2006-11-22 WO PCT/EP2006/068737 patent/WO2007060170A2/en active Application Filing
- 2006-11-23 TW TW095143437A patent/TW200806288A/zh unknown
- 2006-11-24 AR ARP060105184A patent/AR057932A1/es not_active Withdrawn
-
2013
- 2013-02-08 JP JP2013023562A patent/JP5833037B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
CA2625404C (en) | 2015-10-06 |
JP2013082754A (ja) | 2013-05-09 |
US20080113023A1 (en) | 2008-05-15 |
WO2007060170A3 (en) | 2007-09-13 |
AR057932A1 (es) | 2007-12-26 |
EP1959934A2 (en) | 2008-08-27 |
JP2009517366A (ja) | 2009-04-30 |
US8637078B2 (en) | 2014-01-28 |
WO2007060170A2 (en) | 2007-05-31 |
JP5833037B2 (ja) | 2015-12-16 |
CA2625404A1 (en) | 2007-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200806288A (en) | Bilayer tablet comprising Telmisartan and diuretic | |
IL192374A0 (en) | Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol | |
BR122018068298B8 (pt) | processo para a produção de um comprimido seguro contra abuso termo-moldado por extrusão sem descoramento | |
MX2008012731A (es) | Tabletas de paracetamol de liberacion rapida. | |
UA86831C2 (uk) | Композиція таблетки пролонгованого вивільнення, яка містить праміпексол або його фармацевтично прийнятну сіль, спосіб її виготовлення та її застосування | |
MEP42408A (en) | Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof | |
UY27912A1 (es) | Composicion de tabletas de liberacion sostenida de pramipexol | |
MY145089A (en) | Pharmaceutical composition | |
EA201170334A1 (ru) | Устойчивые к раздавливанию таблетки оксикодона, предназначенные для предотвращения случайного неправильного применения и недозволенного употребления | |
MX2009004874A (es) | Formulaciones farmaceuticas estratificadas que comprenden una capa intermediaria que se disuelve rapidamente. | |
UY27720A1 (es) | Aroilpiridinonas monocíclicas, | |
MXPA05005528A (es) | Producto farmaceutico de alergeno. | |
MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
IL184758A0 (en) | New pharmaceutical compositions useful in the transmucosal administration of drugs | |
ECSP077999A (es) | Formulaciones de una sal de bupropion de liberación modificada | |
PL1888514T3 (pl) | Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych | |
MX2008003422A (es) | Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno | |
GB2443793B (en) | Product, method of manufacture and use | |
PE20110119A1 (es) | Asociacion entre ferroquina y artesunato para el tratamiento del paludismo | |
AR056835A1 (es) | Composicion que contiene oligosacaridos | |
MY133322A (en) | Storage stable tablets of fosinopril sodium | |
ATE424814T1 (de) | Schnell zerfallende im mund dispergierbare zusammensetzung mit nicht-filamentösen mitverarbeiteten polyol-teilchen und verkieselter mikrokristalliner cellulose | |
WO2008029417A3 (en) | Pharmaceutical formulation for use in hiv therapy | |
WO2008039351A3 (en) | Method of manufacturing tablets containing pharmacologically active agents | |
WO2008009804A3 (fr) | Tablette multicouche à couches de fragmentation |